[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4413 followers
Created: 2025-05-07 12:30:07 UTC

$BRNS Management Changes:

On May 1, 2025, Barinthus Biotherapeutics plc reported the termination of CFO Gemma Brown effective April 30, 2025, as part of a restructuring plan, appointing CEO William Enright as the new principal financial officer. They also shared preliminary promising results from clinical trials presented on May 7, 2025, showing significant declines in hepatitis B surface antigen levels across treatment groups.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1920093790104158651/c:line.svg)

**Related Topics**
[principal financial](/topic/principal-financial)
[chapter 11](/topic/chapter-11)
[$brns](/topic/$brns)
[sec](/topic/sec)

[Post Link](https://x.com/USCorpFilings/status/1920093790104158651)